Analyst Recommendations

Susquehanna analyst issues POSITIVE recommendation for STM on February 23, 2026 12:38PM ET. The previous analyst recommendation was Positive.STM was trading at $33.62 at issue of the analyst...

February 23, 2026   STM -9.75%

Jefferies analyst issues UNDERPERFORM recommendation for UL on February 23, 2026 11:03AM ET. The previous analyst recommendation was Underperform.UL was trading at $73.23 at issue of the analyst...

February 23, 2026   UL 3.03%

Guggenheim analyst issues BUY recommendation for GMAB on February 23, 2026 11:31AM ET. The previous analyst recommendation was Buy.GMAB was trading at $29.29 at issue of the analyst...

February 23, 2026   GMAB 1.70%

Piper Sandler analyst issues NEUTRAL recommendation for NICE on February 23, 2026 11:44AM ET. The previous analyst recommendation was Neutral.NICE was trading at $117.69 at issue of the...

February 23, 2026   NICE -0.50%

Santander analyst issues OUTPERFORM recommendation for SAN on February 23, 2026 10:19AM ET. The previous analyst recommendation was Buy.SAN was trading at $12.75 at issue of the analyst...

February 23, 2026   SAN -2.57%

Barclays analyst issues OVERWEIGHT recommendation for TS on February 23, 2026 10:53AM ET. The previous analyst recommendation was Overweight.TS was trading at $52.26 at issue of the analyst...

February 23, 2026   TS -3.88%

Goldman Sachs analyst issues NEUTRAL recommendation for RIO on February 22, 2026 10:54AM ET. The previous analyst recommendation was Sell.RIO was trading at $97.09 at issue of the...

February 23, 2026   RIO -4.47%

UBS analyst issues BUY recommendation for ACH on February 22, 2026 07:17PM ET. The previous analyst recommendation was Buy.ACH was trading at $2.61 at issue of the analyst...

February 23, 2026   ACH 1.89%

Jefferies analyst issues HOLD recommendation for INFY on February 22, 2026 08:29PM ET. INFY was trading at $14.65 at issue of the analyst recommendation.The overall analyst consensus :...

February 23, 2026   INFY -1.35%

Barclays analyst issues UNDERWEIGHT recommendation for GSK on February 20, 2026 04:46PM ET. The previous analyst recommendation was Underweight.GSK was trading at $59.455 at issue of the analyst...

February 20, 2026   GSK 0.49%